Quantum BioPharma Ltd. Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019
Quantum BioPharma Ltd. (QNTM) had Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 of $18.87 per share as of 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 · last filed 2026-03-26
- 2025-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $18.87.
- 2025-03-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $9.01.
- 2024-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $7.30.
- 2024-03-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $100.75.
USD/shares
| Period end | Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 |
|---|---|
| 2025-12-31 | $18.87 20-F · filed 2026-03-26 |
| 2025-03-31 | $9.01 6-K/A · filed 2025-06-16 |
| 2024-12-31 | $7.30 20-F · filed 2026-03-26 |
| 2024-03-31 | $100.75 6-K/A · filed 2025-06-16 |
| 2023-12-31 | $100.01 20-F · filed 2026-03-26 |
CAD/shares
| Period end | Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 |
|---|---|
| 2025-09-30 | 18.87 CAD/shares 6-K · filed 2025-11-06 |
| 2025-06-30 | 10.42 CAD/shares 6-K · filed 2025-08-07 |
| 2024-09-30 | 7.30 CAD/shares 6-K · filed 2025-11-06 |
| 2024-06-30 | 95.55 CAD/shares 6-K · filed 2025-08-07 |